ClinicalTrials.govpublic full text
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
bone marrow transplant complications, acute myeloid leukemia, acute lymphoblastic leukemia, adult, myelodysplastic syndromes, chronic myelomonocytic leukemia, allogenic peripheral blood stem cell grafts, phase i, phase ii, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907512
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.